EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serosurvey of Tick-Borne Encephalitis Virus Infection in Romania

Andreea Mădălina Panciu, Cristina Alexandra Cheran, Eliza Daniela Militaru, Claudia Doina Rîciu, Adriana Hristea iD

Pathogens · 2024

DOI: 10.3390/pathogens13030231 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Andreea Mădălina Panciu und 4 weiteren Autor:innen. Beteiligte Einrichtung: "Prof. Dr. Matei Bals" National Institute of Infectious Diseases, 021105 Bucharest, Romania. Hauptthemen laut MEDLINE: Encephalitis, Tick-Borne, Encephalitis Viruses, Tick-Borne, Antibodies, Viral. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer (Germany), Pfizer—Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tick-borne encephalitis (TBE) is a disease with mandatory declaration in the EU since 2012. Information regarding the seroprevalence of the disease across Romania is limited, and only sporadic cases are rarely reported. We aimed to identify new areas of TBEV infection in different counties of Romania.

Methods

We conducted a serosurvey assessing the immune response to TBEV infection in adult populations from rural areas in different counties of the country. Seropositivity was defined by a positive TBEV IgM/IgG ELISA test and confirmed by serum neutralization.

Results

We collected 1116 samples from 15 different localities in 10 counties (divided into endemic/border/non-endemic counties) across Romania. Overall, 26 (2.3%) of the samples were tested positive using the TBEV ELISA assay in six counties. In those counties, 3.7% of sera were positive, varying from 1.4% to 6.9% per county. After performing the neutralization assay, seven (0.6%) samples were confirmed positive, interestingly all from one site in Sibiu County, where the seroprevalence was 9.7%.

Conclusions

The identification of positive serum samples in serosurveys appears to rely on the discovery of TBEV microfoci. Further serological surveys should be conducted in Romania, especially after the identification of positive TBEV patients presenting for medical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalitis, Tick-BorneEncephalitis Viruses, Tick-BorneAntibodies, ViralHumansRomaniaSeroepidemiologic StudiesMaleFemaleAdultMiddle AgedEnzyme-Linked Immunosorbent AssayAgedYoung AdultImmunoglobulin GAdolescentImmunoglobulin MAged, 80 and over

Stichwörter der Autor:innen

RomaniaTBEVserosurvey

Substanzen

Antibodies, ViralImmunoglobulin GImmunoglobulin M

Autor:innen und Institutionen

  • "Prof. Dr. Matei Bals" National Institute of Infectious Diseases, 021105 Bucharest, Romania.
  • Faculty of Medicine, Carol Davila University of Medicine and Pharmacy, 020021 Bucharest, Romania.

ORCID-Profile: Adriana Hristea

Förderung

  • Pfizer (Germany)
  • Pfizer—Research

Zitieren

APA

Panciu, A. M., Cheran, C. A., Militaru, E. D., Rîciu, C. D., & Hristea, A. (2024). Serosurvey of Tick-Borne Encephalitis Virus Infection in Romania. Pathogens. https://doi.org/10.3390/pathogens13030231

Vancouver

Panciu AM, Cheran CA, Militaru ED, Rîciu CD, Hristea A. Serosurvey of Tick-Borne Encephalitis Virus Infection in Romania. Pathogens. 2024. doi:10.3390/pathogens13030231

BibTeX
@article{Panciu2024,
  author = {Panciu, Andreea Mădălina and Cheran, Cristina Alexandra and Militaru, Eliza Daniela and Rîciu, Claudia Doina and Hristea, Adriana},
  title = {Serosurvey of Tick-Borne Encephalitis Virus Infection in Romania},
  journal = {Pathogens},
  year = {2024},
  doi = {10.3390/pathogens13030231}
}
Kostenlos starten →